The Competition and Markets Authority (CMA) has officially launched an inquiry into the merger of Ardonagh-owned broker Atlanta Group and Managing General Agent (MGA) Markerstudy. Acting under section 96(2A) of the Enterprise Act 2002, the regulator aims to assess whether the merger could result in a “substantial lessening of competition within any market or markets in the UK for goods or services.”
Initially announced on September 15, 2023, the acquisition was facilitated by an investment led by Pollen Street Capital and Bain Capital Special Situations, adding a layer of financial prominence to the transaction.
Venus Topco Limited, a subsidiary of Pollen Street, took the initiative by submitting the merger notice to the CMA, adhering to regulatory obligations surrounding significant mergers and acquisitions.
Read more: UK’s CMA Launches Market Study Into Competition In Housebuilding
The CMA’s involvement underscores its commitment to upholding fair competition and preventing anti-competitive practices within the UK business landscape. The inquiry will scrutinize the potential impact of the merger on competition within the markets, ensuring that consumers and businesses continue to benefit from a diverse and competitive marketplace.
The Atlanta Group and Markerstudy merger is of strategic significance within the insurance and brokerage sector. The regulatory scrutiny by the CMA reflects a proactive approach to safeguarding competition and preventing monopolistic tendencies.
Industry stakeholders and market participants will be closely monitoring the CMA’s inquiry, seeking insights into the possible implications of the merger on the competitive landscape. Ardonagh, Markerstudy, and their respective investors are expected to cooperate fully with the CMA throughout the regulatory process, addressing any concerns and providing the necessary information to facilitate a comprehensive evaluation.
Source: Law 360
Featured News
National Association of Realtors Faces New Antitrust Lawsuit Over Membership Rules
Dec 3, 2024 by
CPI
Independent Pharmacies Seek Court Unification in Fight Over Generic Drug Payments
Dec 2, 2024 by
CPI
EU Drops Controversial Merger Tool Following Court Ruling
Dec 2, 2024 by
CPI
Musk Sues to Stop OpenAI, Citing Antitrust Violations and Public Harm
Dec 2, 2024 by
CPI
South Korean AI Chipmakers Rebellions and Sapeon Korea Merge to Compete Globally
Dec 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Moats & Entrenchment
Nov 29, 2024 by
CPI
Assessing the Potential for Antitrust Moats and Trenches in the Generative AI Industry
Nov 29, 2024 by
Allison Holt, Sushrut Jain & Ashley Zhou
How SEP Hold-up Can Lead to Entrenchment
Nov 29, 2024 by
Jay Jurata, Elena Kamenir & Christie Boyden
The Role of Moats in Unlocking Economic Growth
Nov 29, 2024 by
CPI
Overcoming Moats and Entrenchment: Disruptive Innovation in Generative AI May Be More Successful than Regulation
Nov 29, 2024 by
Simon Chisholm & Charlie Whitehead